Source link : https://www.newshealth.biz/health-news/reduced-risk-for-peripheral-neuropathy-tied-to-diabetes-med/
MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, may also help prevent diabetic peripheral neuropathy (DPN), new research suggests. In a large database analysis of patients with type 2 diabetes, those taking tirzepatide had a significantly reduced risk for […]
Author : News Health
Publish date : 2024-06-25 22:10:17
Copyright for syndicated content belongs to the linked Source.
Categories